

[ Mon, Sep 23rd 2024
] - WOPRAI
[ Mon, Sep 23rd 2024
] - WOPRAI
[ Mon, Sep 23rd 2024
] - WOPRAI
[ Mon, Sep 23rd 2024
] - WOPRAI
[ Mon, Sep 23rd 2024
] - WOPRAI
[ Mon, Sep 23rd 2024
] - WOPRAI
[ Mon, Sep 23rd 2024
] - WOPRAI
[ Mon, Sep 23rd 2024
] - WOPRAI
[ Mon, Sep 23rd 2024
] - WOPRAI
[ Mon, Sep 23rd 2024
] - WOPRAI
[ Mon, Sep 23rd 2024
] - WOPRAI
[ Mon, Sep 23rd 2024
] - WOPRAI
[ Mon, Sep 23rd 2024
] - WOPRAI
[ Mon, Sep 23rd 2024
] - WOPRAI
[ Mon, Sep 23rd 2024
] - WOPRAI
[ Mon, Sep 23rd 2024
] - WOPRAI
[ Mon, Sep 23rd 2024
] - WOPRAI
[ Mon, Sep 23rd 2024
] - WOPRAI
[ Mon, Sep 23rd 2024
] - WOPRAI

[ Fri, Sep 20th 2024
] - WOPRAI
[ Fri, Sep 20th 2024
] - WOPRAI
[ Fri, Sep 20th 2024
] - WOPRAI
[ Fri, Sep 20th 2024
] - WOPRAI
[ Fri, Sep 20th 2024
] - WOPRAI
[ Fri, Sep 20th 2024
] - WOPRAI
[ Fri, Sep 20th 2024
] - WOPRAI
[ Fri, Sep 20th 2024
] - WOPRAI
[ Fri, Sep 20th 2024
] - WOPRAI
[ Fri, Sep 20th 2024
] - WOPRAI
Kristen Kluska Reiterated (CAPR) at Buy and Held Target at $8 on, Sep 20th, 2024
Kristen Kluska of Cantor Fitzgerald, Reiterated "Capricor Therapeutics, Inc." (CAPR) at Buy and Held Target at $8 on, Sep 20th, 2024.
Kristen has made no other calls on CAPR in the last 4 months.
There are 3 other peers that have a rating on CAPR. Out of the 3 peers that are also analyzing CAPR, 0 agree with Kristen's Rating of Hold.
These are the ratings of the 3 analyists that currently disagree with Kristen
- Jason McCarthy of "Maxim Group" Reiterated at Strong Buy and Held Target at $12 on, Tuesday, September 17th, 2024
- Joseph Pantginis of "HC Wainwright & Co." Reiterated at Strong Buy and Held Target at $40 on, Tuesday, September 17th, 2024
- Leland Gershell of "Oppenheimer" Maintained at Buy with Increased Target to $15 on, Tuesday, September 17th, 2024
Contributing Sources